• Dr. Michael Spartalis is an Attending Cardiologist, Certified Electrophysiology Specialist, and Certified Cardiac Device Specialist. Currently, an Academic Scholar (Adjunct Lecturer) at the 3rd Department of Cardiology, National and Kapodistrian University of Athens, Clinical Scholar at Harvard Medical School, Associate Editor of European Heart Journal Case Reports, SoMe Consultant at JACC Advances and an Expert on medical devices at the European Commission.

    His work focuses on cardiac electrophysiology, device therapy, and sudden cardiac death, and encompasses a wide array of studies related to diabetes, implantable cardioverter-defibrillators, cardiac resynchronization therapy, rhythm disturbances, and technology innovations including new disruptive wearable technologies improving health care delivery. 

    He has published in leading journals, including the New England Journal of Medicine, Circulation, Journal of Heart and Lung Transplantation, and the Journal of American College of Cardiology. His research activity is documented by the production of 117 published articles in high-impact medical journals, all indexed in PubMed. 

    Among notable honors, he was awarded: Fellow of the European Society of Cardiology (FESC), as a symbol of Scientific Excellence from the European Society of Cardiology in 2017, Fellow of the American College of Cardiology (FACC) Designation from the American College of Cardiology in 2018, Fellow of the European Heart Rhythm Association (FEHRA) honorary recognition from the European Heart Rhythm Association in 2019. In April 2022, he was elected EHRA Nominating Committee member.

    He holds an MD and a PhD from National and Kapodistrian University of Athens, Medical School, a MSc in Thrombosis, Hemorrhage and Transfusion medicine from National and Kapodistrian University of Athens, Medical School, a MHCM from Conservatoire National des Arts et Métiers, and a Master in Interventional Electrophysiology from Università Vita-Salute San Raffaele. Most recently, he completed the Oxford's Leadership Program.